Background and Objectives: Carcinoma of the head and neck is an uncommon pr
imary source of bone metastases. The increasing duration of survival of the
se patients, however, increases the probability of late bone involvement. T
he objective was to identify the frequency, clinical presentation, and clin
ical course of metastatic disease to bone from head and neck primaries.
Methods: A retrospective review was accomplished of the radiographs and nuc
lear medicine studies for 363 cases of squamous cell carcinoma of the head
and neck for whom radiologic studies had been performed. For those with ide
ntified bone involvement, a chart review was performed to identify clinical
presentation, disease course, and outcome.
Results: Only approximately 1% of these patients had clinically demonstrabl
e bone metastases. Eight sites of bone involvement were identified in five
patients, including three pelvic, two femoral, and one each humeral, rib, a
nd thoracic spine lesions. All lesions were purely lytic with motheaten or
permeative borders. Time from primary tumor diagnosis to identification of
metastatic disease ranged from being present at diagnosis to a maximum 3.5
years later. Time from identification of metastatic disease to patient deat
h was no greater than 8 months.
Conclusions: Despite the increasing overall survival of patients with these
carcinomas, distant bone metastases are infrequent, but should be consider
ed a possibility in any patient with a concurrent or past diagnosis of head
and neck carcinoma. The very short time from discovery of bone disseminati
on to death in most of these patients should be taken into consideration wh
en contemplating operative intervention. J. Surg. Oncol. 2000:75:136-140. (
C) 2000 Wiley-Liss, Inc.